D-0305-2020 Class III Terminated
FDA drug recall D-0305-2020 was initiated by Lupin Pharmaceuticals Inc. on Nov 1, 2019 and is designated Class III. Reason for recall: Presence of Foreign substance: identified as a dead ant. The recall status is terminated (terminated Mar 4, 2021). Affected quantity: 30,516 bottles.
Recall details
- Product Type
- Drugs
- Report Date
- Nov 13, 2019
- Initiation Date
- Nov 1, 2019
- Termination Date
- Mar 4, 2021
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 30,516 bottles
Product description
Cefdinir for Oral Suspension USP, 250 mg/5mL,100 mL bottle, Rx only, Manufactured for: Lupin Pharmaceuticals, Inc., Baltimore, Maryland 21202, United States, Manufactured by: Lupin Limited, Mandideep 462 046 INDIA, NDC 68180-723-10
Reason for recall
Presence of Foreign substance: identified as a dead ant.
Distribution pattern
Product was distributed to major distributors/wholesalers throughout the United States.
Code information
Lot #: F802345, F802346, F802347, Exp 11/20
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-0305-2020
- openFDA file date
- Nov 10, 2026
- Loaded by RegDataLab
- Nov 11, 2026